The human body has 40 trillion cells and roughly 200 different cell types. Amongst the diverse cell types lies incredible levels of cellular heterogeneity. There are some big biological questions that stem from single cells, like cancer, a potentially deadly disease starting in one cell out of 40 trillion.
Understanding the human body at the single-cell level has applications in neuroscience, the immune system, blood and more. In fact, many if not all the body’s systems are built on the concept of cellular diversity.
Recent advances in the ability to isolate single cells and amplify their genetic material marked the birth of single-cell genomics.
Join us for Single Cell ONLINE – a virtual 4-part series from global leaders using these technologies to better understand human health, starting on Thursday 9th July at 3 pm BST/ 4 pm CET/ 10 am EST.
Speakers include:
Caroline Gubser Keller, Data Science Site Head in Chemical Biology and Therapeutics, Novartis
Tobias Bergauer, Lab Head Genetics and Genomics, Roche
Anders Stahlberg, Professor, University of Gothenburg and Sahlgrenska Cancer Center
Andreas Keller, Chair for Clinical Bioinformatics, University of Saarland
Zhouchun Shang, Group Leader, MGI
Dan Chang, Single cell sequencing lead, Merck
Ivan K. Lukić, Senior Field Application Scientist, Partek Incorporated
Jonathan Proto, Principal Scientist, Sanofi
Simit Patel, Field Applications Scientist, Partek Incorporated
Rebecca Leary, Lab Head, NGS Diagnostics, Novartis
Webinars:
9th July: Single cell analysis – promises and challenges
“Patient-derived scaffolds uncover tumor promoting factors of the microenvironment” – Anders Stahlberg, Professor, University of Gothenburg and Sahlgrenska Cancer Center
“Overcoming the Complexity of Single Cell Data Analysis” – Ivan K. Lukić, Senior Field Application Scientist, Partek Incorporated
16th July: Single cell for immunoprofiling in Alzheimers
Andreas Keller, Chair for Clinical Bioinformatics, University of Saarland
Zhouchun Shang, Group Leader, MGI
23rd July: Single-cell genomics for drug targets
“Challenges to cell type annotation in patient CNS tissue samples” – Jonathan Proto, Principal Scientist, Sanofi
“Disease associated cell populations for drug discovery” – Caroline Gubser Keller, Data Science Site Head in Chemical Biology and Therapeutics, Novartis
30th July: Clinical applicability of single cell analysis in clinical trials: A discussion
Panellists include:
Dan Chang, Single cell sequencing lead, Merck
Tobias Bergauer, Lab Head Genetics and Genomics, Roche
Rebecca Leary, Lab Head, NGS Diagnostics, Novartis
More speakers to be announced. Keep an eye out for more details!
This series is brought to you with the support of our sponsors, Partek and MGI.
Image credit: Background photo created by kjpargeter – www.freepik.com
